SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange
Act of 1934
Date of Report: September 24, 1996
PLC SYSTEMS INC.
--------------------------------------------------
(Exact Name of Registrant as Specified in Charter)
British Columbia, Canada 0-19561 04-3153858
------------------------ ------- ----------
(State or Other Jurisdiction (Commission (I.R.S. Employer
of Incorporation) File Number) Identification
Number)
10 Forge Park, Franklin, Massachusetts 02038
--------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
(508) 541-8800
------------------------------------------------
(Registrant's Telephone Number, Including Area Code)
TABLE OF CONTENTS
FORM 8-K
September 24, 1996
Item Page
---- ----
Item 5. Other Events 1
Item 7. Exhibits 1
Signature 2
Exhibits 3
i
ITEM 5. OTHER EVENTS.
A copy of the press release of the Registrant dated September 10, 1996
is filed herewith as Exhibit Number 99a. The press release describes the
notification of the Food and Drug Administration to the Registrant allowing the
Registrant to halt the randomization of patients to medical management in
multicenter Transmyocardial Revascularization clinical trials.
A copy of the Complaint for declaratory relief filed September 10,
1996, Cardiogenesis Corp. v. PLC Systems, Inc., et al., U.S.D.C. (N.D. - S.J.),
Civil Action Number C-96 20749 SW (EAI), is filed herewith as Exhibit Number
99b. The Registrant has been named as a defendant in a complaint for declaratory
relief of patent invalidity and non-infringement under 28 U.S.C., Sections 2201
and 2202, with a demand for jury trial.
ITEM 7. EXHIBITS
The following exhibits are filed herewith:
Exhibit
No. Title
99a Press Release of the Registrant dated September 10, 1996
99b Complaint for declaratory relief filed September 10, 1996, CardioGenesis
Corp. v. PLC Systems, Inc., et al., U.S.D.C. (N.D. - S.J.), Civil Action
Number C-96 20749 SW (EAI).
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
PLC SYSTEMS INC.
By:/s/ Patricia L. Murphy
---------------------------
Patricia L. Murphy
Chief Financial Officer
Date: September 24, 1996
2
EXHIBIT INDEX
Exhibit
No. Title
99a Press Release of the Registrant dated September 10, 1996
99b Complaint for declaratory relief filed September 10, 1996, CardioGenesis
Corp. v. PLC Systems, Inc., et al., U.S.D.C. (N.D. - S.J.), Civil Action
Number C-96 20749 SW (EAI).
3